Targeting fasting and post-prandial triglycerides

3' education - Sep. 1, 2013 - Snapshot 2013 - Dr. Joanne M. Donovan

Dr. Joanne Donovan, describes a potential novel approach to target fasting and post-prandial triglycerides with an oral agent that targets intestinal and liver PCSK9

Disclosure
Joanne M. Donovan MD PhD is Chief Medical Officer at Catabasis Pharmaceuticals, Inc

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.